Patient Group Direction Template: Administration of Nuvaxovid XBB.1.5 (Novavax COVID-19 vaccine [recombinant, adjuvanted]) vaccine
Version 2
- Published
- 05 November 2024 (Latest release)
- Type
- Patient group direction
- Author
- Public Health Scotland
- Coronavirus (COVID-19)
- Immunisations
This specimen patient group direction (PGD) template has been produced by Public Health Scotland to assist NHS boards.
NHS boards should amend/adapt this PGD template and must ensure that the PGD is considered and approved in line with local clinical governance arrangements for PGDs.
Please note that this PGD expires on 31 December 2024.
General enquiries
If you have an enquiry relating to this publication, please email .
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.